Skip to Main Content

1,539

Views

0

CrossRef citations to date

0

Altmetric

Article

Ruxolitinib cream monotherapy demonstrates rapid improvement in the extent and signs of mild to moderate atopic dermatitis across head and neck and other anatomic regions in adolescents and adults: pooled results from 2 phase 3 studies

Eric L. Simpsona Department of Dermatology, Oregon Health & Science University, Portland, OR, USAView further author information

,

Robert Bissonnetteb Innovaderm Research, Montreal, Quebec, CanadaView further author information

,

Zelma C. Chiesa Fuxenchc Department of Dermatology, University of Pennsylvania, Philadelphia, PA, USAView further author information

,

Howard Kallenderd Incyte Corporation, Wilmington, DE, USAView further author information

,

Daniel Sturmd Incyte Corporation, Wilmington, DE, USAView further author information

,

Haobo Rend Incyte Corporation, Wilmington, DE, USAView further author information

&

Linda F. Stein Golde Henry Ford Health System, Detroit, MI, USACorrespondence[email protected]
View further author information